Skip to main content
SpringerLink
Log in

Canine Inflammatory Mammary Carcinoma: Histopathology, Immunohistochemistry and Clinical Implications of 21 Cases

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Human inflammatory breast carcinoma (IBC) is the most malignant type of breast cancer with an extremely poor prognosis. The dog is the unique animal species in which spontaneous inflammatory mammary carcinoma (IC) has been reported, although it is not well documented. The purpose of this study was to characterize histopathologically and immunohistochemically the canine IC, considering associated clinical features. Twenty-one dogs diagnosed with IC and with known clinical and necropsy data were included in the study. Tissue samples from necropsies underwent a histopathological review and an immunohistochemical study (Ki-67, estrogen receptor (ER), progesterone receptor (PR), and P53 tumor suppressor protein). The histological study revealed several types of carcinomas (solid, tubular, papillary, and adenosquamous) and three lipid-rich carcinomas. All tumors were ER negative. Two histological patterns of neoplastic dermal infiltration were observed: tubular/papillary and sarcomatous-like. Dermal sarcomatous-like infiltration was significantly related to previous treatments with progestagens (p=0.006), primary type of IC (p=0.03), extreme local pain (p=0.02), reduced observation of emboli in dermal lymphatic vessels (p=0.01), and increased expression of p53 (p=0.001). PR expression was significantly higher in secondary post-surgical IC (p=0.04). The absence of PR was related to the existence of pulmonary metastases at necropsy (p=0.04). Canine primary IC is the most aggressive form of this disease with distinct histopathological and immunohistochemical characteristics. Progestins and endocrine-related mechanisms seem to be involved in canine IC development. Canine IC could serve as a spontaneous model for human IBC, particularly in studies concerned with new therapeutics approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tavassoli FA: Pathology of the Breast. 2nd edn, McGraw-Hill, New York, 1999, pp 519-522, 538-541

    Google Scholar 

  2. Levine PH, Steinhorn SC, Ries LG, Levine AJ: Inflammatory breast cancer. The experience of the Surveillance, Epidemiology, and End Results (SEER) Program. J Natl Cancer Inst 74: 291-297, 1985

    Google Scholar 

  3. Ellis DL, Teitelbaum SL: Inflammatory carcinoma of the breast: a pathologic definition. Cancer 33: 1045-1047, 1974

    Google Scholar 

  4. Somlo G, Doroshow JH, Forman SJ, Odom-Maryon T, Lee J, Chow W, Hamasaki V, Leong L, Morgan Jr R, Margolin K, Raschko J, Shibata S, Tetef M, Yen Y, Simpson J, Molina A: High-dose chemotherapy and stem cell rescue in the treatment of high risk breast cancer: prognostic indicators of progression-free and overall survival. J Clin Oncol 15: 2882-2893, 1997

    Google Scholar 

  5. Victor SJ, Horwitz EM, Kini VR, Martinez AA, Pettinga JE, Dmuchowski CF, Decker DA, Wilner FM, Vicini FA: Impact of clinical, pathologic, and treatment-related factors of patients with locally advanced breast cancer treated with multimodality therapy. Am J Clin Oncol 22: 119-125, 1999

    Google Scholar 

  6. van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD: A novel putative low-affinity insulin-like growth factorbinding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5(9): 2511-2519, 1999

    Google Scholar 

  7. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD: RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60(20): 5832-5838, 2000 Oct 15

    Google Scholar 

  8. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD: Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160(2): 579-584, 2002

    Google Scholar 

  9. van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD: RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2(5): 418-425, 2000

    Google Scholar 

  10. Kleer CG, van Golen KL, Braun T, Merajver SD: Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol 14(5): 458-464, 2001

    Google Scholar 

  11. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH: A novel human xenograft model of inflammatory breast cancer. Cancer Res 59: 5079-5084, 1999

    Google Scholar 

  12. Susaneck SJ, Allen TA, Hoopes J, Withrow SJ, Macy DW: Inflammatory mammary carcinoma in the dog. J Am An Hosp Assoc 19: 971-976, 1983

    Google Scholar 

  13. Perez-Alenza MD, Tabanera E, Peña L: Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J Am VetMed Assoc 219(8): 1110-1114, 2001

    Google Scholar 

  14. Taylor GW, Meltzer A: Inflammatory carcinoma of the breast. Ann Surg 33: 33-49, 1938

    Google Scholar 

  15. Richards FJ, Lewison EF: Inflammatory carcinoma of the breast. Surg Gynecol Obstet 113: 729-732, 1961

    Google Scholar 

  16. Attia-Sobol J, Ferriere JP, Cure H, Kwiatkowski F, Achard JL, Verrelle P, Feillel V, De Latour M, Lafaye C, Deloche C et al.: Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis. Eur J Cancer 29A: 1081-1088, 1993

    Google Scholar 

  17. Nishimura R, Koyama H, Kasumi F, Takashima S, Kobayashi S, Komaki K, Ohkawa T, Shin E, Kodama H, Fukutomi T, Nishi T, Sonoo H, Sano S, Kimishima I, Nakaue K, Nakamura S, Kusama M, Okumura K: A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgery. Oncology 55: 391-399, 1998

    Google Scholar 

  18. Misdorp W, Else RW, Helmén E, Lipscomb TP: Histological Classification of Mammary Tumors of the Dog and Cat. Second Series. Vol 7, Armed Forces Institute of Pathology and World Health Organization, Washington, 1999

    Google Scholar 

  19. Elston CW, Ellis IO: Method for grading breast cancer. J Clin Pathol 46: 189-190, 1993

    Google Scholar 

  20. Dixon W: BMDP Statistical Software. Release 7.0, University of California Press, Los Angeles, 1993

    Google Scholar 

  21. Chambler AF, Drew PJ, Hill AD, Darzi A, Monson JR: Inflammatory breast carcinoma. Surg Oncol 4: 245-254, 1995

    Google Scholar 

  22. Tardivon AA, Viala J, Corvellec Rudelli A, Guinebretiere JM, Vanel D: Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol 24(2): 124-130, 1997

    Google Scholar 

  23. Dershaw DD, Moore MP, Liberman L, Deutch BM: Inflammatory breast carcinoma: mammographic findings. Radiology 190: 831-834, 1994

    Google Scholar 

  24. Tsubura A, Hatano T, Murata A, Shoji T, Shikata N, Morii S: Breast carcinoma in patients receiving neuroleptic therapy. Morphologic and clinico-pathologic features of thirteen cases. Acta Pathol Japon 7: 494-499, 1991

    Google Scholar 

  25. IBC Research Foundation. Research of inflammatory breast cancer and related matters. Available from URL: http://www.ibcresearch.org/research/

  26. Peña L, Nieto AI, Perez-Alenza MD, Cuesta P, Castaño M: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest 10: 237-246, 1998

    Google Scholar 

  27. Brooks HL, Mandava N, Pizzi WF, Shah S: Inflammatory breast carcinoma: a community hospital experience. J AmColl Surg 186: 622-629, 1998

    Google Scholar 

  28. Ueno NT, Buzdar AU, Singletary SE, Ames FC, McNeese MD, Holmes FA Theriault RL, Strom EA, Wasaff BJ, Asmar L, Frye D, Hortobagyi GN: Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M.D. Anderson Cancer Center. Cancer Chemoth Pharm 40: 321-329, 1997

    Google Scholar 

  29. Fleming RYD, Asmar L, Buzdar AU, McNeese MD, Ames FC, Ross MI: Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol 4: 452-461, 1997

    Google Scholar 

  30. Wilke D, Colwell B, Dewar R: Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. Am Surgeon 64: 428-431, 1998

    Google Scholar 

  31. Atlan D, Chevallier B, Sheng RG: Tamoxifen for the treatment of metastatic inflammatory breast carcinoma. Am J Clin Oncol 18: 74-77, 1995

    Google Scholar 

  32. Nieto A, Peña L, Perez Alenza MD, Sánchez MA, Flores JM, Castaño M: Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathological associations and prognostic significance. Vet Pathol 37: 239-247, 2000

    Google Scholar 

  33. Falette N, Paperin MP, Treilleux I, Gratadour AC, Peloux N, Mignotte H, Tooke N, Lofman E, Inganas M, Bremond A, Ozturk M, Puisieux A: Prognostic value of p53 gene mutation in a large series of node-negative breast cancer patients. Cancer Res 58: 1451-1455, 1998

    Google Scholar 

  34. Wakui S, Muto T, Yokoo K, Yokoo R, Takahashi H, Masaoka T, Hano H, Furusato M: Prognostic status of p53 gene mutation in canine mammary carcinoma. Anticancer Res 21: 611-616, 2001

    Google Scholar 

  35. Chang S, Parker SL, Pham T, Buzdar A, Hursting SD: Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer 82: 2366-2372, 1998

    Google Scholar 

  36. Berg JW, Hutter RV: Breast cancer. Cancer 75(suppl 1): 275-282, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Animal Pathology II, Veterinary Teaching Hospital, School of Veterinary Medicine, Complutense University, Madrid, Spain

    Laura Peña, M. Dolores Perez-Alenza, Antonio Rodriguez-Bertos & Ana Nieto

Authors
  1. Laura Peña
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Dolores Perez-Alenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Rodriguez-Bertos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ana Nieto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peña, L., Dolores Perez-Alenza, M., Rodriguez-Bertos, A. et al. Canine Inflammatory Mammary Carcinoma: Histopathology, Immunohistochemistry and Clinical Implications of 21 Cases. Breast Cancer Res Treat 78, 141–148 (2003). https://doi.org/10.1023/A:1022991802116

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022991802116

Search

Navigation